Lifetime management of aortic valve disease: Aligning surgical and transcatheter armamentarium to set the tone for the present and the future

Transcatheter aortic valve replacement (TAVR) has already received the green light for high‐, intermediate‐ and low‐risk profiles and is an alternative for all patients regardless of age. It is clear that there has been a push towards the use of TAVR in younger and younger patients (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiac surgery 2022-01, Vol.37 (1), p.205-213
Hauptverfasser:	Sá, Michel Pompeu, Ramlawi, Basel, Sicouri, Serge, Torregrossa, Gianluca, Al Abri, Qasim, Kempfert, Jörg, Kofler, Markus, Falk, Volkmar, Unbehaun, Axel, Van Praet, Karel M.
Format:	Artikel
Sprache:	eng
Schlagworte:	aortic valve Aortic Valve Disease aortic valve stenosis Aortic Valve Stenosis - surgery cardiac surgical procedure cardiovascular surgical procedures Heart Valve Prosthesis Implantation Humans Risk Factors transcatheter aortic valve implantation transcatheter aortic valve replacement Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Transcatheter aortic valve replacement (TAVR) has already received the green light for high‐, intermediate‐ and low‐risk profiles and is an alternative for all patients regardless of age. It is clear that there has been a push towards the use of TAVR in younger and younger patients (
ISSN:	0886-0440 1540-8191
DOI:	10.1111/jocs.16110